RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/7882
https://w3id.org/ripe/ripe-kg/retraction-notice/7882
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA6DBDE4E81DF5F0FA |
prov:used |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
prism:doi |
10.2739/kurumemedj.49 |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
prism:publicationDate |
2017-04-13 |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
prism:publicationName |
The Kurume Medical Journal |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
dcterms:publisher |
ripekg:publisher/RIPEPFE75C6003D98CD7CKurume University School of Medicine |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
dcterms:title |
The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
http://purl.org/spar/cito/retracts |
ripekg:work/10.2739%2Fkurumemedj.57.117 |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
rdf:type |
owl:Thing |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
owl:sameAs |
https://semopenalex.org/work/W28408729 |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA6DBDE4E81DF5F0FA |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA6DBDE4E81DF5F0FA |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
ripe:concerns |
ripekg:work/10.2739%2Fkurumemedj.57.117 |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
ripe:rationale |
Investigation by Journal/Publisher;Investigation by Third Party;Misconduct by Author |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
ripe:retractionWatchRecordId |
7882 |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-human-1-1 |
ripekg:retraction-notice/7882The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-inspectai-1-1 |